LORIUM · 5 mg LYOPHILISED VIALCJC-1295 DAC
CJC-1295 (with DAC) is an advanced GHRH analogue structurally modified with a Drug Affinity Complex to maximize systemic stability and clinical longevity. By binding naturally to serum albumin in the bloodstream, this premium protocol extends its biological half-life to nearly a week, providing continuous, high-efficiency stimulation of growth hormone and IGF-1 axes.
Researched effects
Effects observed in the cited literature. Individual results are not guaranteed. Statements have not been evaluated by the FDA.
Sustained GH Elevation
Studied to support a robust 2 to 10-fold increase in growth hormone for over 6 days.
Prolonged IGF-1 Rise
Keeps active IGF-1 levels elevated parallelly for up to 9–11 days.
Convenient Optimization
Delivers maximum clinical efficacy with a reduced weekly dosing routine.
Extended Longevity
Features a weekly biological half-life via albumin conjugation.
Cumulative Baseline Effects
Maintains stable systemic hormone pools above baseline for up to 28 days.
Lean Muscle Support
Accelerates optimal protein synthesis and deep muscle tissue repair.
Advanced Fat Metabolism
Enhances structural fat oxidation and balances cellular metabolic rates.
Specifications
Clinical references
- Teichman, S. L., et al. (2006). Prolonged Stimulation of GH and IGF-1 by a Long-Acting GHRH Analog. J Clin Endocrinol Metab, 91(3).
- Ionescu, M., et al. (2006). Sustained Increases in GH and IGF-I Levels with Subcutaneous CJC-1295. Clin Endocrinol, 64(2).
- Teichman, S. L., et al. (2005). Pharmacokinetic Properties of a Long-Acting GHRH Analog. Drug Dev Res, 66(4).
- Jetté, L., et al. (2005). Identification of CJC-1295 as a Long-Lasting GRF Analog via Albumin Bioconjugates. Endocrinology, 146(7).
More in Growth
CJC-1295 (no DAC)
A GHRH analogue that selectively stimulates the anterior pituitary to increase growth hormone and IGF-1 while preserving natural pulsatile release.
IGF-1 LR3
A potent synthetic analogue of human insulin-like growth factor-1 with an arginine substitution and extended sequence for sustained anabolic activation and deep tissue repair.
Ipamorelin
A highly selective synthetic pentapeptide growth hormone secretagogue that stimulates pituitary GH release via the GHS-R1a receptor without disrupting other endocrine pathways.